Living with high blood pressure?
This clinical study is exploring a new investigational medication to help manage mild to moderate high blood pressure, and you may qualify to participate.
The study will evaluate the effectiveness and safety of an investigational medication called QCZ484, compared to a placebo (an inactive substance).
Eligible participants may also receive compensation for time and travel.
Join us in shaping the future of high blood pressure treatment — see if you qualify today.
Location(s): Lavilla, FL
Age: 18 – 75 Years old
Gender: All
Compensation: Paid time and travel, if qualified
Medical Exams: No cost for study-related exams
Insurance Requirements: No insurance required
What is a clinical trial?
A clinical trial is a research study designed to evaluate new medical treatments, drugs, or devices to determine their safety and effectiveness.
Who can participate in a clinical trial?
Each trial has a specific eligibility criteria, such as age, medical history, and current health status. Our team will assess if you qualify.
Are clinial trial safe?
Yes. All trials are carefully regulated by health authorities and ethics committees to ensure participant safety. You will be closely monitored throughout the study.
Will I be compensated for participating?
Some studies offer compensation for time and travel expenses. Details vary by study and will be discussed during the screening process.
Do I need health insurance to participate?
No. Clinical trials do not require health insurance, and the study sponsor typically covers costs related to the research.
Can I leave a clinical trial at any time?
Yes, participation is voluntary, and you can withdraw at any time for any reason.
What happens after a clinical trial ends?
You may have a follow-up period where the research team monitors your health. In some cases, you may have continued access to the treatment.
Advancing Research, Centered on You
As part of the Rovia Clinical Research Site Network, ECIR delivers patient-focused clinical trials powered by national expertise and local care. With locations in Florida (Jacksonville, Lake City, St. Augustine), Georgia (Canton, Macon), and Tennessee (Jefferson City), we’re committed to advancing Type 2 diabetes research while serving the needs of the communities we call home.